A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen-Reference-Cited by-同舟云学术

A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen

Published:2021-10-22 Issue: Volume: Page:
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

King Christopher S¹,Flaherty Kevin R.²,Glassberg Marilyn K³,Lancaster Lisa⁴,Raghu Ganesh⁵,Swigris Jeffrey J⁶,Argula Rahul G⁷,Dudenhofer Rosemarie A⁴,Ettinger Neil A⁸,Feldman Jeremy⁹,Johri Shilpa¹⁰,Fernandes P¹¹,Parsley Ed¹¹,Shah Parag¹¹,Nathan Steven D¹²

Affiliation:

1. Inova Fairfax Hospital, 23146, Advanced Lung Disease and Lung Transplant Clinic, Falls Church, Virginia, United States;

2. University of Michigan, Ann Arbor, United States

3. University of Arizona Medical Center - University Campus, 22165, Tucson, Arizona, United States

4. Vanderbilt University Medical Center, 12328, Nashville, Tennessee, United States

5. University of Washington Medical Center, 21617, Division of Pulmonary and Critical Care Medicine, Seattle, Washington, United States

6. National Jewish Health, 2930, Medicine, Denver, Colorado, United States

7. Medical University of South Carolina, Pulmonary, Critical Care, Allergy & Sleep Medicine, Charleston , South Carolina, United States

8. St Lukes Rehabilitation Hospital, 575996, Chesterfield, Missouri, United States

9. Arizona Pulmonary Specialists, Pheonix, United States

10. Pulmonary Associates of Richmond Inc, 92331, Richmond, Virginia, United States

11. Bellerophon Therapeutics, Warren, New Jersey, United States

12. Inova Fairfax Hospital, 23146, Advanced Lung Disease and Transplant Program, Falls Church, Virginia, United States

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event;Trials;2024-08-03

2. Evidence from recent clinical trials in fibrotic interstitial lung diseases;Current Opinion in Pulmonary Medicine;2024-07-04

3. Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance;npj Digital Medicine;2024-05-16

4. The acute effect of inhaled nitric oxide on the exercise capacity of patients with advanced interstitial lung disease: a randomized controlled trial;BMC Pulmonary Medicine;2024-05-10

5. Case report: Inhaled nitric oxide rescued a hypoxemia patient caused by dermatomyositis complicated with interstitial pneumonia;Frontiers in Medicine;2024-05-03